Tag: Christopher Carey

Christopher Carey is a Vice President and Equity Research Analyst at Bank of America Merrill Lynch covering consumer stocks including cannabis companies like Aurora Cannabis Inc.Β (NYSE:ACB)Β (TSX:ACB), Canopy Growth Corp.Β (NYSE:CGC) (TSX:WEED), HEXO Corp.Β (NYSE:HEXO)Β (TSX:HEXO), and more. Prior to joining Merrill Lynch, Christopher Carey was an Equity Research Associate at B. Riley FBR covering transportation and logistics companies. Christopher Carey received his BA in Economics from Boston College and an MBA from the University of South Carolina’s Daria Moore School of Business.